Report Israel - Medicaments Containing Insulin But not Antibiotics in Measured Doses - Market Analysis, Forecast, Size, Trends and Insights for 499$
Report Update Apr 1, 2024

Israel - Medicaments Containing Insulin But not Antibiotics in Measured Doses - Market Analysis, Forecast, Size, Trends and Insights

Single report
Sent by email within 24h (Mon-Fri)
Subscription
Online access and download
from $350/month

Get instant access to more than 2 million reports, dashboards, and datasets on the IndexBox Platform.

View Pricing

Israel: Market for Medicaments Containing Insulin But Not Antibiotics In Measured Doses 2024

Market Size for Medicaments Containing Insulin But Not Antibiotics In Measured Doses in Israel

The Israeli prophylactic medicaments containing insulin market surged to $X in 2022, increasing by X% against the previous year. This figure reflects the total revenues of producers and importers (excluding logistics costs, retail marketing costs, and retailers' margins, which will be included in the final consumer price). In general, consumption saw buoyant growth. Prophylactic medicaments containing insulin consumption peaked at $X in 2020; however, from 2021 to 2022, consumption stood at a somewhat lower figure.

Exports of Medicaments Containing Insulin But Not Antibiotics In Measured Doses

Exports from Israel

In 2022, after two years of decline, there was significant decline in shipments abroad of medicaments containing insulin but not antibiotics in measured doses, when their volume decreased by X% to X kg. Overall, exports, however, showed a significant expansion. The pace of growth appeared the most rapid in 2019 with an increase of X% against the previous year. The exports peaked at X tons in 2021, and then contracted significantly in the following year.

In value terms, prophylactic medicaments containing insulin exports fell markedly to $X in 2022. In general, exports, however, enjoyed a strong increase. The pace of growth appeared the most rapid in 2019 when exports increased by X%. Over the period under review, the exports reached the maximum at $X in 2021, and then dropped remarkably in the following year.

Exports by Country

Moldova (X kg) was the main destination for prophylactic medicaments containing insulin exports from Israel, accounting for a X% share of total exports. Moreover, prophylactic medicaments containing insulin exports to Moldova exceeded the volume sent to the second major destination, Ukraine (X kg), threefold. The third position in this ranking was held by Germany (X kg), with a X% share.

From 2016 to 2022, the average annual rate of growth in terms of volume to Moldova was relatively modest. Exports to the other major destinations recorded the following average annual rates of exports growth: Ukraine (X% per year) and Germany (X% per year).

In value terms, Moldova ($X) emerged as the key foreign market for medicaments containing insulin but not antibiotics in measured doses exports from Israel, comprising X% of total exports. The second position in the ranking was held by Ukraine ($X), with a X% share of total exports. It was followed by Germany, with a X% share.

From 2016 to 2022, the average annual rate of growth in terms of value to Moldova was relatively modest. Exports to the other major destinations recorded the following average annual rates of exports growth: Ukraine (X% per year) and Germany (X% per year).

Export Prices by Country

The average prophylactic medicaments containing insulin export price stood at $X per ton in 2022, shrinking by X% against the previous year. Overall, the export price saw a abrupt slump. The pace of growth appeared the most rapid in 2019 an increase of X%. Over the period under review, the average export prices attained the maximum at $X per ton in 2016; however, from 2017 to 2022, the export prices failed to regain momentum.

Prices varied noticeably by country of destination: amid the top suppliers, the country with the highest price was the United States ($X,000 per ton), while the average price for exports to Germany ($X per ton) was amongst the lowest.

From 2016 to 2022, the most notable rate of growth in terms of prices was recorded for supplies to Germany (X%), while the prices for the other major destinations experienced mixed trend patterns.

Imports of Medicaments Containing Insulin But Not Antibiotics In Measured Doses

Imports into Israel

In 2022, the amount of medicaments containing insulin but not antibiotics in measured doses imported into Israel soared to X tons, picking up by X% compared with the previous year's figure. Overall, imports continue to indicate strong growth. The most prominent rate of growth was recorded in 2019 when imports increased by X% against the previous year. Imports peaked at X tons in 2020; however, from 2021 to 2022, imports failed to regain momentum.

In value terms, prophylactic medicaments containing insulin imports rose markedly to $X in 2022. Over the period under review, imports enjoyed strong growth. The pace of growth appeared the most rapid in 2019 with an increase of X%. Over the period under review, imports reached the peak figure at $X in 2020; however, from 2021 to 2022, imports stood at a somewhat lower figure.

Imports by Country

Denmark (X tons), France (X tons) and Switzerland (X tons) were the main suppliers of prophylactic medicaments containing insulin imports to Israel, together accounting for X% of total imports.

From 2012 to 2022, the most notable rate of growth in terms of purchases, amongst the main suppliers, was attained by Switzerland (with a CAGR of X%), while imports for the other leaders experienced more modest paces of growth.

In value terms, the largest prophylactic medicaments containing insulin suppliers to Israel were Denmark ($X), France ($X) and Switzerland ($X), with a combined X% share of total imports.

Switzerland, with a CAGR of X%, recorded the highest rates of growth with regard to the value of imports, in terms of the main suppliers over the period under review, while purchases for the other leaders experienced more modest paces of growth.

Import Prices by Country

In 2022, the average prophylactic medicaments containing insulin import price amounted to $X per ton, waning by X% against the previous year. In general, the import price showed a perceptible descent. The pace of growth was the most pronounced in 2015 an increase of X% against the previous year. The import price peaked at $X per ton in 2018; however, from 2019 to 2022, import prices stood at a somewhat lower figure.

Average prices varied noticeably amongst the major supplying countries. In 2022, amid the top importers, the highest price was recorded for prices from Germany ($X per ton) and Denmark ($X per ton), while the price for France ($X per ton) and Switzerland ($X per ton) were amongst the lowest.

From 2012 to 2022, the most notable rate of growth in terms of prices was attained by Brazil (X%), while the prices for the other major suppliers experienced more modest paces of growth.

Source: IndexBox Platform

Frequently Asked Questions (FAQ) :

The countries with the highest volumes of consumption in 2023 were China, the United States and India, together comprising 52% of global consumption.
The countries with the highest volumes of production in 2022 were China, the United States and India, together comprising 52% of global production.
In value terms, the largest prophylactic medicaments containing insulin suppliers to Israel were Denmark, France and Switzerland, together comprising 99% of total imports.
In value terms, Moldova emerged as the key foreign market for medicaments containing insulin but not antibiotics in measured doses exports from Israel, comprising 72% of total exports. The second position in the ranking was held by Ukraine, with a 26% share of total exports. It was followed by Germany, with a 1.7% share.
In 2022, the average prophylactic medicaments containing insulin export price amounted to $240,000 per ton, dropping by -26.8% against the previous year.
In 2022, the average prophylactic medicaments containing insulin import price amounted to $226,866 per ton, with a decrease of -15.6% against the previous year.

This report provides an in-depth analysis of the market for prophylactic medicaments containing insulin in Israel. Within it, you will discover the latest data on market trends and opportunities by country, consumption, production and price developments, as well as the global trade (imports and exports). The forecast exhibits the market prospects through 2030.

Product coverage:

  • Prodcom 21201260 - Medicaments containing insulin but not antibiotics, for therapeutic or prophylactic uses, put up in measured doses or for retail sale

Country coverage:

  • Israel

Data coverage:

  • Market volume and value
  • Per Capita consumption
  • Forecast of the market dynamics in the medium term
  • Trade (exports and imports) in Israel
  • Export and import prices
  • Market trends, drivers and restraints
  • Key market players and their profiles

Reasons to buy this report:

  • Take advantage of the latest data
  • Find deeper insights into current market developments
  • Discover vital success factors affecting the market

This report is designed for manufacturers, distributors, importers, and wholesalers, as well as for investors, consultants and advisors.

In this report, you can find information that helps you to make informed decisions on the following issues:

  1. How to diversify your business and benefit from new market opportunities
  2. How to load your idle production capacity
  3. How to boost your sales on overseas markets
  4. How to increase your profit margins
  5. How to make your supply chain more sustainable
  6. How to reduce your production and supply chain costs
  7. How to outsource production to other countries
  8. How to prepare your business for global expansion

While doing this research, we combine the accumulated expertise of our analysts and the capabilities of artificial intelligence. The AI-based platform, developed by our data scientists, constitutes the key working tool for business analysts, empowering them to discover deep insights and ideas from the marketing data.

  1. 1. INTRODUCTION

    Making Data-Driven Decisions to Grow Your Business

    1. REPORT DESCRIPTION
    2. RESEARCH METHODOLOGY AND AI PLATFORM
    3. DATA-DRIVEN DECISIONS FOR YOUR BUSINESS
    4. GLOSSARY AND SPECIFIC TERMS
  2. 2. EXECUTIVE SUMMARY

    A Quick Overview of Market Performance

    1. KEY FINDINGS
    2. MARKET TRENDS This Chapter is Available Only for the Professional Edition PRO
  3. 3. MARKET OVERVIEW

    Understanding the Current State of The Market and Its Prospects

    1. MARKET SIZE
    2. MARKET STRUCTURE
    3. TRADE BALANCE
    4. PER CAPITA CONSUMPTION
    5. MARKET FORECAST TO 2030
  4. 4. MOST PROMISING PRODUCT

    Finding New Products to Diversify Your Business

    This Chapter is Available Only for the Professional Edition PRO
    1. TOP PRODUCTS TO DIVERSIFY YOUR BUSINESS
    2. BEST-SELLING PRODUCTS
    3. MOST CONSUMED PRODUCT
    4. MOST TRADED PRODUCT
    5. MOST PROFITABLE PRODUCT FOR EXPORT
  5. 5. MOST PROMISING SUPPLYING COUNTRIES

    Choosing the Best Countries to Establish Your Sustainable Supply Chain

    This Chapter is Available Only for the Professional Edition PRO
    1. TOP COUNTRIES TO SOURCE YOUR PRODUCT
    2. TOP PRODUCING COUNTRIES
    3. TOP EXPORTING COUNTRIES
    4. LOW-COST EXPORTING COUNTRIES
  6. 6. MOST PROMISING OVERSEAS MARKETS

    Choosing the Best Countries to Boost Your Exports

    This Chapter is Available Only for the Professional Edition PRO
    1. TOP OVERSEAS MARKETS FOR EXPORTING YOUR PRODUCT
    2. TOP CONSUMING MARKETS
    3. UNSATURATED MARKETS
    4. TOP IMPORTING MARKETS
    5. MOST PROFITABLE MARKETS
  7. 7. PRODUCTION

    The Latest Trends and Insights into The Industry

    1. PRODUCTION VOLUME AND VALUE
  8. 8. IMPORTS

    The Largest Import Supplying Countries

    1. IMPORTS FROM 2012–2023
    2. IMPORTS BY COUNTRY
    3. IMPORT PRICES BY COUNTRY
  9. 9. EXPORTS

    The Largest Destinations for Exports

    1. EXPORTS FROM 2012–2023
    2. EXPORTS BY COUNTRY
    3. EXPORT PRICES BY COUNTRY
  10. 10. PROFILES OF MAJOR PRODUCERS

    The Largest Producers on The Market and Their Profiles

    This Chapter is Available Only for the Professional Edition PRO
  11. LIST OF TABLES

    1. Key Findings In 2023
    2. Market Volume, In Physical Terms, 2012–2023
    3. Market Value, 2012–2023
    4. Per Capita Consumption In 2012-2023
    5. Imports, In Physical Terms, By Country, 2012–2023
    6. Imports, In Value Terms, By Country, 2012–2023
    7. Import Prices, By Country Of Origin, 2012–2023
    8. Exports, In Physical Terms, By Country, 2012–2023
    9. Exports, In Value Terms, By Country, 2012–2023
    10. Export Prices, By Country Of Destination, 2012–2023
  12. LIST OF FIGURES

    1. Market Volume, In Physical Terms, 2012–2023
    2. Market Value, 2012–2023
    3. Market Structure – Domestic Supply vs. Imports, In Physical Terms, 2012-2023
    4. Market Structure – Domestic Supply vs. Imports, In Value Terms, 2012-2023
    5. Trade Balance, In Physical Terms, 2012-2023
    6. Trade Balance, In Value Terms, 2012-2023
    7. Per Capita Consumption, 2012-2023
    8. Market Volume Forecast to 2030
    9. Market Value Forecast to 2030
    10. Products: Market Size And Growth, By Type
    11. Products: Average Per Capita Consumption, By Type
    12. Products: Exports And Growth, By Type
    13. Products: Export Prices And Growth, By Type
    14. Production Volume And Growth
    15. Exports And Growth
    16. Export Prices And Growth
    17. Market Size And Growth
    18. Per Capita Consumption
    19. Imports And Growth
    20. Import Prices
    21. Production, In Physical Terms, 2012–2023
    22. Production, In Value Terms, 2012–2023
    23. Imports, In Physical Terms, 2012–2023
    24. Imports, In Value Terms, 2012–2023
    25. Imports, In Physical Terms, By Country, 2023
    26. Imports, In Physical Terms, By Country, 2012–2023
    27. Imports, In Value Terms, By Country, 2012–2023
    28. Import Prices, By Country Of Origin, 2012–2023
    29. Exports, In Physical Terms, 2012–2023
    30. Exports, In Value Terms, 2012–2023
    31. Exports, In Physical Terms, By Country, 2023
    32. Exports, In Physical Terms, By Country, 2012–2023
    33. Exports, In Value Terms, By Country, 2012–2023
    34. Export Prices, By Country Of Destination, 2012–2023

Recommended reports

Free Data: Medicaments Containing Insulin But Not Antibiotics In Measured Doses - Israel